文献速递神经肿瘤

低级别胶质瘤诊断与外科治疗的创新进展

Innovations in the Diagnosis and Surgical Management of Low-Grade Gliomas.
PubMed 文献 · World Neurosurg · 2022-01-01

低级别胶质瘤预后历来被认为较好,手术是主要治疗手段。分子特征分析进展催生新分类系统并识别新实体,影像组学有助于无创预测分子分型,术中组织分析更精准,新手术技术与辅助手段及免疫治疗等新兴内科治疗丰富了管理策略。本文综述低级别胶质瘤的当代管理与治疗创新。

要点

  • 分子特征分析进展促成新的分类系统并识别出既往未认识的肿瘤实体。
  • 影像组学可通过无创检测预测特定肿瘤的分子特征。
  • 更精准的术中肿瘤组织分析方法有助于手术规划。

核心结论

  • 新的前瞻性遗传与分子数据将有助于描绘更好的治疗范式,并将在未来数年继续改变中枢神经系统肿瘤的分类。
  • 影像组学进展将有助于通过无创检测预测特定肿瘤的分子特征。
  • 由新手术技术、术中辅助手段及免疫治疗领域新兴内科治疗推动的手术结局改善,丰富了这些病变的管理。

主要发现

  • 低级别胶质瘤是一大类可在不同人生阶段发病的肿瘤,其预后历来被认为较好,手术是主要治疗手段。
  • 分子特征分析进展催生了更新的分类系统,增进了对不同肿瘤生物学行为的理解,并识别出既往未认识的实体。
  • 更精准的术中肿瘤组织分析方法将有助于手术规划。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Low-grade gliomas are a broad category of tumors that can manifest at different stages of life. As a group, their prognosis has historically been considered to be favorable, and surgery is a mainstay of treatment. Advances in the molecular characterization of individual lesions has led to newer classification systems, a better understanding of the biological behavior of different neoplasms, and the identification of previously unrecognized entities. New prospective genetic and molecular data will help delineate better treatment paradigms and will continue to change the taxonomy of central nervous system tumors in the coming years. Advances in the field of radiomics will help predict the molecular profile of a particular tumor through noninvasive testing. Similarly, more precise methods of intraoperative tumor tissue analysis will aid surgical planning. Improved surgical outcomes propelled by novel surgical techniques and intraoperative adjuncts and emerging forms of medical treatment in the field of immunotherapy have enriched the management of these lesions. We review the contemporary management and innovations in the treatment of low-grade gliomas.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Uribe-Cardenas R, Giantini-Larsen AM, Garton A, et al. Innovations in the Diagnosis and Surgical Management of Low-Grade Gliomas. World Neurosurg. 2022. PMID: 36192864. doi:10.1016/j.wneu.2022.06.070

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。